Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug
January 25, 2023Medical Communications
Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …
Eli Lilly plans to invest $450m at production site in Research Triangle Park
January 25, 2023Manufacturing and Production
US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …
Poxel given EC’s Orphan Drug Designation for rare metabolic disorders
January 25, 2023Research and Development
Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …
Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1
January 25, 2023Medical Communications
US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …
finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation
January 24, 2023Business Services
London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …
UK seeing exodus of R&D activity, research reveals
January 24, 2023Business Services
London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …
Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence
January 24, 2023Business Services
London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …
2022 Novo Holdings Seed Investments team Review/Business Update
January 24, 2023Business Services
Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …
Global Company Foot Science International Choose Onyx Health
January 24, 2023Business Services
Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …
Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg
January 24, 2023Business Services
Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …
Europe plans further antibiotic shortage countermeasures
January 24, 2023Medical Communications
With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …
WHO issues a “call to action” after cough syrup deaths
January 24, 2023Medical Communications
WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …
TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes
January 24, 2023Research and Development
TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …
Novo Nordisk accused of violating FDA’s Fair Balance advertising policy
January 24, 2023Sales and Marketing
Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo …
Modus Therapeutics submits patent application for sevuparin in kidney disease
January 23, 2023Business Services
STOCKHOLM, SWEDEN – 23 January 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)
January 23, 2023Business Services
Dublin, Ireland – January 23, 2023 – Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound …
First Indian intranasal COVID-19 vaccine about to launch
January 23, 2023Medical Communications
Indian biotech company Bharat Biotech plans to launch its new intranasal COVID-19 vaccine iNCOVACC on the 26 January 2023 ‒ …
FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy
January 23, 2023Medical Communications
The FDA has granted Breakthrough Device Designation for US-based medical technology company CardioRenal for their RenalGuard Therapy device, used to …
FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment
January 23, 2023Research and Development
Seagen Inc has been given FDA Accelerated Approval for its colorectal drug TUKYSA (tucatinib) after reviewing positive data from the …
AI and motion capture technology used to monitor movement disorders
January 23, 2023Research and Development
A team of researchers have been developing a monitoring system to assess the progression of movement disorders. The new technology …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
